Skip to main content
. 2018 Sep 21;11:6119–6128. doi: 10.2147/OTT.S172717

Figure 3.

Figure 3

Figure 3

Meta-analysis of the short-term efficacy and survival benefit of apatinib.

Notes: (A) DCR; (B) ORR; (C) PFS; and (D) OS. Weights are from random-effects analysis.

Abbreviations: DCR, disease control rate; ORR, objective response rate; PFS, progression-free survival; OS, overall survival.